x
Filter:
Filters applied
- Oncology
- Cooperberg, Matthew RRemove Cooperberg, Matthew R filter
- UrologyRemove Urology filter
Publication Date
Please choose a date range between 2017 and 2019.
Author
- Alvarez, JoAnn Rudd1
- Amling, Christopher L1
- Aronson, William J1
- Balakrishnan, Ashwin S1
- Barocas, Daniel A1
- Broering, Jeanette M1
- Carroll, Peter R1
- Chen, Vivien1
- Cowan, Janet E1
- Freedland, Stephen J1
- Goodman, Michael1
- Greenfield, Sheldon1
- Hamilton, Ann S1
- Hashibe, Mia1
- Hoffman, Karen E1
- Howard, Lauren E1
- Kane, Christopher J1
- Kaplan, Sherrie H1
- Koyama, Tatsuki1
- Lang, Maximilian F1
- Moreira, Daniel M1
- Paddock, Lisa E1
- Penson, David F1
- Resnick, Matthew J1
Oncology
3 Results
- Oncology
Trends and Predictors of Adjuvant Therapy for Adverse Features Following Radical Prostatectomy: An Analysis From Cancer of the Prostate Strategic Urologic Research Endeavor
UrologyVol. 131p157–165Published online: May 28, 2019- Ashwin S. Balakrishnan
- Shoujun Zhao
- Janet E. Cowan
- Jeanette M. Broering
- Matthew R. Cooperberg
- Peter R. Carroll
Cited in Scopus: 5To determine trends and predictors of adjuvant therapy in patients with adverse features at radical prostatectomy (RP), and to investigate the associations of adjuvant therapy and adverse feature type with survival. - Oncology
Timing of Prostate-specific Antigen Nadir After Radical Prostatectomy and Risk of Biochemical Recurrence
UrologyVol. 108p129–134Published online: July 19, 2017- Stephanie L. Skove
- Lauren E. Howard
- William J. Aronson
- Martha K. Terris
- Christopher J. Kane
- Christopher L. Amling
- and others
Cited in Scopus: 15To evaluate the association between the prostate-specific antigen (PSA) nadir level and the time to nadir (TTN) with biochemical recurrence (BCR) risk after radical prostatectomy (RP) in the Shared Equal-Access Research Cancer Hospital (SEARCH) database. - Oncology
The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort
UrologyVol. 103p173–178Published online: February 10, 2017- Maximilian F. Lang
- Mark D. Tyson
- JoAnn Rudd Alvarez
- Tatsuki Koyama
- Karen E. Hoffman
- Matthew J. Resnick
- and others
Cited in Scopus: 14To evaluate the influence of psychosocial factors such as prostate cancer (PCa) anxiety, social support, participation in medical decision-making (PDM), and educational level on patient decisions to discontinue PCa active surveillance (AS) in the absence of disease progression.